|
Volumn 15, Issue 3, 2002, Pages 295-301
|
Central pathways for cough in man - Unanswered questions
|
Author keywords
Central pharmacology; Cholinergic; Cough; Dopaminergic; Opiates
|
Indexed keywords
ANTITUSSIVE AGENT;
ATROPINE;
BROMOCRIPTINE;
CAPSAICIN;
CHOLINERGIC RECEPTOR;
DOPAMINE RECEPTOR;
HALOPERIDOL;
LEVODOPA;
MORPHINE;
NEUROTRANSMITTER;
OPIATE;
PHYSOSTIGMINE;
PIZOTIFEN;
SEROTONIN 1 RECEPTOR;
SEROTONIN 2 RECEPTOR;
SEROTONIN RECEPTOR;
CHOLINERGIC SYSTEM;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COUGHING;
CROSSOVER PROCEDURE;
DOPAMINERGIC SYSTEM;
DOUBLE BLIND PROCEDURE;
DROWSINESS;
DRUG EFFECT;
DRUG EFFICACY;
DRUG POTENTIATION;
HUMAN;
HUMAN EXPERIMENT;
MEDULLA OBLONGATA;
NORMAL HUMAN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REFLEX;
SEDATION;
VISUAL ANALOG SCALE;
|
EID: 0036308330
PISSN: 10945539
EISSN: None
Source Type: Journal
DOI: 10.1006/pupt.2002.0344 Document Type: Conference Paper |
Times cited : (24)
|
References (43)
|